Autopsy report · NCT03507127

Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1

“Low rate of enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 2 months before it stopped.
• 5 participants enrolled.
• Results were posted on the registry 2 years 11 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Brown University

Sponsor type

University, hospital or other

Conditions

Tobacco Dependence

Interventions

Varenicline; Placebo

Participants

5

Sites

1

Countries

United States

Trials that died the same way

• Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib
  “low enrollment rate” (97% match in meaning)
• Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
  “Low enrollment rates.” (92% match in meaning)
• Prophylactic Phenobarbital After Neonatal Seizures
  “Inadequate rate of enrollment” (89% match in meaning)
• Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas
  “low enrollment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.